Put the Vanc Down, Flip it and Reverse it : Comparison of Vancomycin and Daptomycin Healthcare Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy

Amber C Streifel,Katie Luis,Monark Nakrani,Diana Yu,Monica K Sikka,Cara D Varley,Alyse Douglass,Heather Mayer,Kathleen Young,James S Lewis
DOI: https://doi.org/10.1093/ofid/ofae438
2024-07-25
Open Forum Infectious Diseases
Abstract:Abstract Vancomycin and daptomycin are frequently used in outpatient parenteral antimicrobial therapy (OPAT). We analyze healthcare utilization and cost to the healthcare system for vancomycin versus daptomycin in the outpatient setting and find that vancomycin results in significantly higher healthcare utilization and similar cost per course compared to daptomycin in OPAT.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?